Back to Agenda
Opportunity, Caution or Reluctance: Global Trends for Regulating AI in Pharmaceutical Manufacturing
Session Chair(s)
Gert Thurau, DRSC, PHD
Head of CMC Regulatory Policy for Manufacturing Technology Innovation in
F. Hoffmann-La Roche Ltd, Switzerland
Artificial intelligence is revolutionizing drug manufacturing, yet regulations are still catching up. With key guidance from the EU and US in development, a proactive and collaborative approach is needed for global regulatory alignment, ensuring AI i
Learning Objective : Identify and summarize regulatory trends specific to AI use in Manufacturing; Distinguish AI use in manufacturing from use in product development.
Have an account?